Kalpana Sharma

Could COVID-19 Help Fight Cancer? A Groundbreaking Study Finds Out the Link

Cancer and COVID

The COVID-19 pandemic was a traumatic experience for most, claiming countless lives and forcing many to suffer in isolation. The fear and disruption caused by the virus during 2020-2021 extended beyond the pandemic itself, affecting the diagnosis and treatment of other life-threatening diseases like <span><a href="https://www.healthandme.com/health/cancer">cancer</a></span> and tuberculosis. However, what if we told you that the very virus that upended our lives might hold the key to fighting cancer?

Cancer is one of the leading causes of death worldwide. During the pandemic, some doctors noticed something intriguing: cancer patients who contracted COVID-19 experienced tumor shrinkage or reduced growth. Initially, it was unclear if this was a coincidence or if there was a deeper connection.

A recent study led by researchers at the Northwestern Medicine Canning Thoracic Institute, published in The Journal of Clinical Investigation last month, sheds light on this phenomenon. This groundbreaking research could pave the way for new treatments to combat cancer, especially metastasis—the process by which cancer spreads to different parts of the body.

Dr. Ankit Bharat, chief of thoracic surgery at Northwestern University, and his team found that the SARS-CoV-2 virus influences a type of immune cell in the body called monocytes. Normally, cancer cells manipulate monocytes to shield themselves from the immune system's attack. However, the researchers discovered that the presence of the COVID-19 virus alters this behavior.

The viral RNA appears to transform monocytes into a rare type of immune cell, scientifically termed inducible nonclassical monocytes. These transformed cells can be enhanced with specific drugs to infiltrate tumors and metastatic regions. Once inside, they break down the cancer’s protective shield, enabling the body’s immune system to identify and attack the cancer cells more effectively.

This is a significant breakthrough, particularly for tackling cancer metastasis, which remains a major challenge in cancer treatment. Inside the tumors, these transformed monocytes trigger the production of natural killer cells—specialized immune cells that directly destroy cancer. The study has already shown promising results in mouse models for cancers such as melanoma, breast, and colon cancer.

The findings offer hope for innovative treatments and underscore the unexpected ways in which the virus could contribute to medical advancements. While the COVID-19 pandemic left a trail of devastation, its complex interactions with the human body might open new doors in the fight against cancer.

The COVID-19 pandemic shook the entire world, changing lives, economies, and healthcare systems. While it brought immense suffering, studies like this remind us of the hidden potential for breakthroughs through adversity. Cancer, one of the most deadly diseases affecting people across all age groups, continues to devastate lives without discrimination. This research not only unveils a fascinating connection between SARS-CoV-2 and cancer but also marks the beginning of a new hope. If utilised effectively, these findings could lead to revolutionary treatments, offering hope in the relentless fight against a disease that knows no boundaries.

Health Conditions A-Z

health

cancer

COVID

covid can attack cancer

new cancer study

breakthrough cancer study

Sore Biceps After Difficult Gym Session? Yoga Asanas To Help With Sore Arms

What's The Difference Between Abs And Core? 5 Most Effective Exercises For Each

Childhood High Blood Pressure Could Be Caused By ‘Forever Chemicals’

Health News

Common Mistakes You Are Making While Walking

Exercises You Should Do At Home When You Skip Gym

Common Mistakes You May Be Making While Working Out

Ways You Are Runing Your Weight Loss Journey

Beyond Fruits – How To Retain Hydration And Stay Safe In Summers

Can This Extremely Hot Weather Trigger Our Mental Health?

You Are Hurting Your Gut Health With These Habits

Avoid The Heat With These Indoor Exercises

Stay Sharp! Activities That Keep Cognitive Diseases At Bay

Protect Your Cardiovascular Health With These Heart Healthy Foods

Ways To Ease Nighttime Anxiety

Smoothie Ideas That Can Help With Weight Loss

Low Fat Foods That Are Actually Unhealthy

All Suryanamaskar Poses And How To Do Them

Do Changing Seasons Affect Your Weight?

Can Heatwave Affect Your Diet?

Heatwave To Monsoon: Health Concerns With Seasonal Changes

Standing Exercises That Help You Burn Calories

Reasons To Do Dancing As A Workout

Why Summer Fruits Are A Great Addition To Your Diet?

What Should You Avoid For Your Bladder?

Lower-Body Exercises For Strong Foundation

Healthy Drinks That Improve Your Digestion

World Tobacco Day: Unexpected Ways Smoking Can Affect You

Seasonal Mood Swings? How Weather Affects Mental Health

Is Calorie Counting Healthy? Dos And Don’ts

Heat-Related Illnesses That You Should Know

Menstrual Hygiene Day: Tips On Period Hygiene

​Add These High Protein Vegetarian Meals To Your Diet​

Top 10 Workouts That Burn Most Calorie

Makhana Season – Healthy &amp; Quick Foxnut Recipes

Monsoon Ahead – Tips On Building Rainy Season Immunity

Do You Have Prickly Heat Rash – Symptoms, Causes And Treatment

Healthy No-Cook Recipes You Can Try

How Do You Calorie Count – Numbers And Nutrients

Unexpected Signs Of Dehydration – Safety And Precaution Measures

Leg Exercises You Can Do At Home To Build Strength

Foods That Promote Skin Elasticity

Must-Do Chest Exercises You Can Try At Home

What Are The Symptoms Of JN.1 COVID-19 Strain?

The COVID-19 pandemic was a traumatic experience for most, claiming countless lives and forcing many to suffer in isolation. The fear and disruption caused by the virus during 2020-2021 extended beyond the pandemic itself, affecting the diagnosis and treatment of other life-threatening diseases like cancer and tuberculosis. However, what if we told you that the very virus that upended our lives might hold the key to fighting cancer?Cancer is one of the leading causes of death worldwide. During the pandemic, some doctors noticed something intriguing: cancer patients who contracted COVID-19 experienced tumor shrinkage or reduced growth. Initially, it was unclear if this was a coincidence or if there was a deeper connection.A recent study led by researchers at the Northwestern Medicine Canning Thoracic Institute, published in The Journal of Clinical Investigation last month, sheds light on this phenomenon. This groundbreaking research could pave the way for new treatments to combat cancer, especially metastasis—the process by which cancer spreads to different parts of the body.Dr. Ankit Bharat, chief of thoracic surgery at Northwestern University, and his team found that the SARS-CoV-2 virus influences a type of immune cell in the body called monocytes. Normally, cancer cells manipulate monocytes to shield themselves from the immune system's attack. However, the researchers discovered that the presence of the COVID-19 virus alters this behavior.The viral RNA appears to transform monocytes into a rare type of immune cell, scientifically termed inducible nonclassical monocytes. These transformed cells can be enhanced with specific drugs to infiltrate tumors and metastatic regions. Once inside, they break down the cancer’s protective shield, enabling the body’s immune system to identify and attack the cancer cells more effectively.This is a significant breakthrough, particularly for tackling cancer metastasis, which remains a major challenge in cancer treatment. Inside the tumors, these transformed monocytes trigger the production of natural killer cells—specialized immune cells that directly destroy cancer. The study has already shown promising results in mouse models for cancers such as melanoma, breast, and colon cancer.The findings offer hope for innovative treatments and underscore the unexpected ways in which the virus could contribute to medical advancements. While the COVID-19 pandemic left a trail of devastation, its complex interactions with the human body might open new doors in the fight against cancer.The COVID-19 pandemic shook the entire world, changing lives, economies, and healthcare systems. While it brought immense suffering, studies like this remind us of the hidden potential for breakthroughs through adversity. Cancer, one of the most deadly diseases affecting people across all age groups, continues to devastate lives without discrimination. This research not only unveils a fascinating connection between SARS-CoV-2 and cancer but also marks the beginning of a new hope. If utilised effectively, these findings could lead to revolutionary treatments, offering hope in the relentless fight against a disease that knows no boundaries.

could covid-19 help fight cancer? a groundbreaking study finds out the link

Health and Me

Ishita Roy

World Blood Donor Day 2025: Theme, Significance, And History

Blood Donor Day: Theme, Significance, And History

Health & Wellness

World Blood Donor Day 2025: Thinking of Donating Blood? A Doctor Answers All Your Doubts

world blood donor day 2025: thinking of donating blood? a doctor answers all your doubts

Alarming Signs of Heart Blockages You Can Spot At Home, Cardiologist Shares Life Saving Tips

alarming signs of heart blockages you can spot at home, cardiologist shares life saving tips

World’s First ‘Trojan Horse’ Blood Cancer Drug Rolled Out By NHS In England

world’s first ‘trojan horse’ blood cancer drug rolled out by nhs in england

Chiropractor Visit Turns Into Horror, Woman Says Neck Crack Tore Her Artery- What You Should Know Before Your First Chiropractic Visit?

chiropractor visit turns into horror, woman says neck crack tore her artery- what you should know before your first chiropractic visit?

Every year on June 14, <span>World Blood Donor Day</span> is observed. As per the <span>World Health Organization</span> (WHO), the world celebrates World <span>Blood Donor Day</span>, a global tribute to the millions of voluntary, unpaid blood donors who give others a second chance at life. 

Each time you donate blood, you’re giving more than a life-saving gift—you’re enabling critical medical tests that guide treatment and improve care. This World Blood Donor Day, remember: your donation isn’t just for emergencies, it plays a vital role in everyday healthcare too.

<h4>History of World Blood Donor Day</h4>

The World Blood Donor day dates back to 2004, when it was established by the WHO and is partners. The aim for this was to create a global recognition for he contributions of voluntary donors and to encourage safe blood practices in every country. 

Since then, it has become an essential health campaign that brings attention to the need for regular donation. The day also celebrates unsung heroes who, through this simple ac, save lives. 

<h4>World Blood Donor Day 2025 Theme</h4>

This year, as notes WHO, the theme is "Give blood, give hope, together we save lives". 

This year’s World Blood Donor Day campaign, with the slogan “Give blood, give hope: together we save lives,” emphasizes the life-changing role blood donors play in saving lives. It underscores the power of community and collective action, showcasing how a simple act of donating blood can create a ripple effect of hope for those in need. Through the sharing of personal stories from both recipients and donors, the campaign aims to inspire more individuals, particularly young adults, to take part in blood donation—whether as first-time donors or as regular contributors.

The campaign will feature, as WHO notes, a variety of activities to celebrate and acknowledge the efforts of blood donors. These could include commemorative events, workshops, social media initiatives, donor appreciation ceremonies, and special broadcasts to honor those who give blood. In addition, musical and artistic performances may be held to express gratitude, while impactful stories will be shared to raise awareness about the importance of <span>blood donation</span>. This year’s objectives are to increase public awareness about the critical need for blood donations, encourage both new and returning donors to donate regularly, and promote solidarity and compassion through these life-saving acts. Furthermore, the campaign seeks to rally support from governments and global partners to ensure sustainable national blood programs, aiming for universal access to safe blood transfusion worldwide.

<h4>World Blood Donor Day Significance</h4>

This day encourages more and more people to donate blood and save a life. Blood transfusions provide life-saving support, notes WHO. This is especially true for women who experience bleeding related to pregnancy and childbirth, or children who suffer from severe anemia due to malaria or malnutrition. 

Other scenarios, notes WHO, where blood transfusion helps include, complex medical procedures, patients with sickle-cell disease, thalassemia, hemophilia, or immune deficiency disorder, or for emergency responses, in cases of natural disasters or armed conflicts.

world blood donor day

world health organization

health news

blood donor day

blood donation

Every year on June 14, World Blood Donor Day is observed. As per the World Health Organization (WHO), the world celebrates World Blood Donor Day, a global tribute to the millions of voluntary, unpaid blood donors who give others a second chance at life. Each time you donate blood, you’re giving more than a life-saving gift—you’re enabling critical medical tests that guide treatment and improve care. This World Blood Donor Day, remember: your donation isn’t just for emergencies, it plays a vital role in everyday healthcare too.History of World Blood Donor DayThe World Blood Donor day dates back to 2004, when it was established by the WHO and is partners. The aim for this was to create a global recognition for he contributions of voluntary donors and to encourage safe blood practices in every country. Since then, it has become an essential health campaign that brings attention to the need for regular donation. The day also celebrates unsung heroes who, through this simple ac, save lives. World Blood Donor Day 2025 ThemeThis year, as notes WHO, the theme is "Give blood, give hope, together we save lives". This year’s World Blood Donor Day campaign, with the slogan “Give blood, give hope: together we save lives,” emphasizes the life-changing role blood donors play in saving lives. It underscores the power of community and collective action, showcasing how a simple act of donating blood can create a ripple effect of hope for those in need. Through the sharing of personal stories from both recipients and donors, the campaign aims to inspire more individuals, particularly young adults, to take part in blood donation—whether as first-time donors or as regular contributors.The campaign will feature, as WHO notes, a variety of activities to celebrate and acknowledge the efforts of blood donors. These could include commemorative events, workshops, social media initiatives, donor appreciation ceremonies, and special broadcasts to honor those who give blood. In addition, musical and artistic performances may be held to express gratitude, while impactful stories will be shared to raise awareness about the importance of blood donation. This year’s objectives are to increase public awareness about the critical need for blood donations, encourage both new and returning donors to donate regularly, and promote solidarity and compassion through these life-saving acts. Furthermore, the campaign seeks to rally support from governments and global partners to ensure sustainable national blood programs, aiming for universal access to safe blood transfusion worldwide.World Blood Donor Day SignificanceThis day encourages more and more people to donate blood and save a life. Blood transfusions provide life-saving support, notes WHO. This is especially true for women who experience bleeding related to pregnancy and childbirth, or children who suffer from severe anemia due to malaria or malnutrition. Other scenarios, notes WHO, where blood transfusion helps include, complex medical procedures, patients with sickle-cell disease, thalassemia, hemophilia, or immune deficiency disorder, or for emergency responses, in cases of natural disasters or armed conflicts.

world blood donor day 2025: theme, significance, and history

Tanya Dutt

Social Media Isn’t Just Addictive—It’s Potentially Depressing Your Teen, Study Finds

AI Therapy Gone Wrong: Psychiatrist Reveals How Chatbots Are Failing Vulnerable Teens

ai therapy gone wrong: psychiatrist reveals how chatbots are failing vulnerable teens

Nutrition

Can Low Calorie Diet Impact Your Mental Health?

can low calorie diet impact your mental health?

Lack Of Sleep Can Alter A Teen's Brain And Also Cause Behavioral Issues: Study

lack of sleep can alter a teen's brain and also cause behavioral issues: study

Smartphone Tool Can Now Detect Early Warning Signs Of Huntington’s Disease In 5 Minutes, Finds Study

smartphone tool can now detect early warning signs of huntington’s disease in 5 minutes, finds study

On the surface, social media is just a harmless distractiona virtual playground where teens bond over memes, music, and makeup tips but behind filters and faddish trends, there is a deepening concern for <span>mental health</span>. Emerging evidence indicates that for preteens, scrolling through carefully crafted lives may not only define them it could be quietly undermining their emotional health. A new study now verifies what many mental health professionals and parents have long suspected: social media isn't only addictive—it's potentially driving a more profound wave of depression in today's kids.

Social media is a daily habit for many teenagers and preteens. With TikTok, Instagram, and Snapchat dominating their screen hours, it has become their primary platform for expression, entertainment, and social interaction but beneath the endless scrolling and viral memes is a mounting public health issue: rising data indicates social media use is correlated with rising depression rates among young users. A recent study from UC San Francisco puts this issue into sharper relief, indicating that social media does not just mirror mental illness in children—it could potentially be causing it.

A study led by Dr. Jason Nagata of the Department of Pediatrics at UCSF and published in JAMA Network Open tracked close to 12,000 children ages 9 through 13. By using within-person longitudinal data, researchers could tease out the cause-and-effect link between depression and social media use. What they found was, in a word, sobering: while social media usage went up from seven minutes a day to 73 minutes every three years, symptoms of depression increased by 35%. Most importantly, the study explained that although greater social media usage had resulted in greater depressive symptoms, the opposite was not the case—already-existing depressive symptoms did not cause a rise in screen time.

<h2>Hidden Risks Lurking Behind the Screen</h2>

Why does social media exert such a strong influence on preteen mental health? While the exact mechanisms remain under investigation, researchers suspect several culprits. One is cyberbullying—a separate study by Nagata and his team, published in The Lancet Regional Health – Americas, found that 11- to 12-year-olds who experienced cyberbullying were over 2.6 times more likely to report suicidal thoughts or attempts within a year. Alarmed, they were also much more likely to use substances like marijuana, nicotine, and alcohol.

Another contributing factor is disturbed sleep. The blue light from screens can interfere with melatonin levels, and emotionally stimulating content can make it hard for young users to relax at night. Poor sleep over time is very closely linked to deteriorating mental health, adding to the stress of social media use.

<h2>What is the Paradox of Connection?</h2>

Even with the bad data, social media also serves as the place where kids make and sustain friendships. During a post-pandemic era in which in-person socialization was curtailed, a number of adolescents became dependent upon social media as a lifeline. The paradox, therefore, exists in balancing the psychological detriment against the real social benefits of such sites.

This paradox is a challenge to parents, caregivers, and policymakers. Forcing adolescents away altogether is unrealistic or counterintuitive. Proactive, subtle approaches to healthier involvement are the recommendations of experts instead.

<h2>How Parents Can Take Charge and Change?</h2>

American Academy of Pediatrics (AAP) suggests the use of tools such as the Family Media Plan, which promotes open discussion and clear boundaries around screen time. "Just telling kids to 'get off your phone' doesn't really work," says Dr. Nagata. "Parents can model the way with open, nonjudgmental discussions."

<ul><li>Assigning screen times, e.g., family meals or bedtime.</li><li>Promoting activities that are free from technology and emphasize physical and emotional health, e.g., sports, arts, or journaling.</li><li>Watching for indicators of digital distress—mood swings, withdrawal from social interactions, and disruption of sleep patterns.</li></ul>

Assisting children to critically assess the information they consume, especially in terms of body image and diet fads like the recently prohibited #skinnytok on TikTok.

With over 2.4 million users of TikTok in Tennessee alone, and millions more across the country, social media is obviously not going anywhere. That doesn't mean, however, that its dangers need to be dismissed. Research such as that by UCSF is a much-needed wake-up call, compelling families as well as tech firms to recognize the mental health cost of social sites.

From inaccessible hashtags such as #skinnytok to the more subtle, mundane pressures of edited perfection, the online world is shaping the mental topography of the young in real time. Awareness, discussion, and empathy need to be at the forefront of how we steer our youngsters through this changing landscape.

The answer isn't to shut down social media, but to reimagine its place in kids' lives. Integrating scientific research with compassionate parenting and responsible technology design, we can build a world where social media supports instead of destroys because at the end of the day, it's not only about shielding our teens from depression, but empowering them with the ability to flourish, online and offline.

mental health

teen social media depression

preteens mental health

ucsf depression study

cyberbullying effects

social media risks teens

kids screen time effects

mental health and tiktok

On the surface, social media is just a harmless distractiona virtual playground where teens bond over memes, music, and makeup tips but behind filters and faddish trends, there is a deepening concern for mental health. Emerging evidence indicates that for preteens, scrolling through carefully crafted lives may not only define them it could be quietly undermining their emotional health. A new study now verifies what many mental health professionals and parents have long suspected: social media isn't only addictive—it's potentially driving a more profound wave of depression in today's kids.Social media is a daily habit for many teenagers and preteens. With TikTok, Instagram, and Snapchat dominating their screen hours, it has become their primary platform for expression, entertainment, and social interaction but beneath the endless scrolling and viral memes is a mounting public health issue: rising data indicates social media use is correlated with rising depression rates among young users. A recent study from UC San Francisco puts this issue into sharper relief, indicating that social media does not just mirror mental illness in children—it could potentially be causing it.A study led by Dr. Jason Nagata of the Department of Pediatrics at UCSF and published in JAMA Network Open tracked close to 12,000 children ages 9 through 13. By using within-person longitudinal data, researchers could tease out the cause-and-effect link between depression and social media use. What they found was, in a word, sobering: while social media usage went up from seven minutes a day to 73 minutes every three years, symptoms of depression increased by 35%. Most importantly, the study explained that although greater social media usage had resulted in greater depressive symptoms, the opposite was not the case—already-existing depressive symptoms did not cause a rise in screen time.Hidden Risks Lurking Behind the ScreenWhy does social media exert such a strong influence on preteen mental health? While the exact mechanisms remain under investigation, researchers suspect several culprits. One is cyberbullying—a separate study by Nagata and his team, published in The Lancet Regional Health – Americas, found that 11- to 12-year-olds who experienced cyberbullying were over 2.6 times more likely to report suicidal thoughts or attempts within a year. Alarmed, they were also much more likely to use substances like marijuana, nicotine, and alcohol.Another contributing factor is disturbed sleep. The blue light from screens can interfere with melatonin levels, and emotionally stimulating content can make it hard for young users to relax at night. Poor sleep over time is very closely linked to deteriorating mental health, adding to the stress of social media use.What is the Paradox of Connection?Even with the bad data, social media also serves as the place where kids make and sustain friendships. During a post-pandemic era in which in-person socialization was curtailed, a number of adolescents became dependent upon social media as a lifeline. The paradox, therefore, exists in balancing the psychological detriment against the real social benefits of such sites.This paradox is a challenge to parents, caregivers, and policymakers. Forcing adolescents away altogether is unrealistic or counterintuitive. Proactive, subtle approaches to healthier involvement are the recommendations of experts instead.How Parents Can Take Charge and Change?American Academy of Pediatrics (AAP) suggests the use of tools such as the Family Media Plan, which promotes open discussion and clear boundaries around screen time. "Just telling kids to 'get off your phone' doesn't really work," says Dr. Nagata. "Parents can model the way with open, nonjudgmental discussions."Some strategies that are suggested are:Assigning screen times, e.g., family meals or bedtime.Promoting activities that are free from technology and emphasize physical and emotional health, e.g., sports, arts, or journaling.Watching for indicators of digital distress—mood swings, withdrawal from social interactions, and disruption of sleep patterns.Assisting children to critically assess the information they consume, especially in terms of body image and diet fads like the recently prohibited #skinnytok on TikTok.With over 2.4 million users of TikTok in Tennessee alone, and millions more across the country, social media is obviously not going anywhere. That doesn't mean, however, that its dangers need to be dismissed. Research such as that by UCSF is a much-needed wake-up call, compelling families as well as tech firms to recognize the mental health cost of social sites.From inaccessible hashtags such as #skinnytok to the more subtle, mundane pressures of edited perfection, the online world is shaping the mental topography of the young in real time. Awareness, discussion, and empathy need to be at the forefront of how we steer our youngsters through this changing landscape.The answer isn't to shut down social media, but to reimagine its place in kids' lives. Integrating scientific research with compassionate parenting and responsible technology design, we can build a world where social media supports instead of destroys because at the end of the day, it's not only about shielding our teens from depression, but empowering them with the ability to flourish, online and offline.

social media isn’t just addictive—it’s potentially depressing your teen, study finds

New Once-a-Week Pill May Transform Schizophrenia Treatment, Lancet Study Finds

new once-a-week pill may transform schizophrenia treatment, lancet study finds

Can Ozempic Help Manage PCOS Symptoms?

can ozempic help manage pcos symptoms?

Appendix Cancer vs. Diverticulitis: Symptoms, Causes And How To Tell the Difference Early

appendix cancer vs. diverticulitis: symptoms, causes and how to tell the difference early

The England National Health Service (NHS) is the world's first healthcare system to offer a revolutionary <span>blood cancer</span> treatment called a "Trojan horse" drug. The trailblazing treatment, officially known as <span>belantamab mafodotin</span>, has the potential to add years to the lives of thousands of patients fighting multiple myeloma, a vicious and currently untreatable form of bone marrow cancer.

This innovation, now being rolled out to eligible patients throughout England, highlights the revolutionary promise of precision medicine and targeted treatments to change cancer care.

At the center of this medical innovation is belantamab mafodotin, also known as Blenrep and produced by GlaxoSmithKline. In contrast to traditional chemotherapy that gets into both healthy and cancer cells, this new medication uses a targeted approach: it binds to myeloma cells, enters them quietly, and delivers a fatal dose of chemotherapy directly within, effectively killing the malignancy from the inside out.

This "Trojan horse" metaphor comes from Greek mythology, as Greek warriors entered the city of Troy disguised within a wooden horse. In the same way, this drug corrupts cancer cells by smuggling a toxic payload into them disguised as an antibody—spared most healthy tissues in the process.

NHS England National Clinical Director for Cancer Professor Peter Johnson called the treatment "life-changing" and said, "Myeloma is an aggressive blood cancer, but the advent of belantamab mafodotin brings with it a new hope of highly extended disease control.

Multiple myeloma is a plasma cancer that arises in plasma cells present in the bone marrow. Although there are continued advances in medicine, the disease is still incurable and relapsing in nature. The majority of patients have a pattern of recurrence after remission, requiring multiple treatment lines.

Trials of belantamab mafodotin, particularly in combination with other drugs such as bortezomib and dexamethasone, have shown that the treatment can stop disease from progressing for a period of three years—three years longer than the 13-month postponement achieved with the drug of choice at present, daratumumab.

The National Institute for Health and Care Excellence (NICE), having checked the effectiveness and value for money, accelerated approval for the rollout of the treatment. NICE director Helen Knight stated, "This recommendation shows our determination to get patients the best treatment quickly while protecting value for the taxpayer." 

The NHS rollout will first address about 1,500 patients per year in England that have relapsed or are resistant to their existing treatments. These are often those with advanced myeloma who have run out of other standard treatments.

Significantly, this represents a move toward personalized, next-generation treatments being accessible through public healthcare facilities—an accomplishment welcomed by health activists and oncologists alike.

Shelagh McKinlay, Myeloma UK's Director of Research and Advocacy, hailed the announcement: "We have campaigned aggressively for the last year to get this drug approved. It will change the lives of thousands of myeloma patients."

Paul Silvester, who is 60 and from Sheffield, was diagnosed with multiple myeloma in 2023. When ordinary treatment and even a bone marrow transplant did not halt the disease, he was put on an early-access trial for belantamab mafodotin at the Royal Hallamshire Hospital.

The change was almost instant," he explained. "In the first two or three weeks following the first dose, I was in remission. I like to think this treatment has brought the party balloons into the house."

Paul is now in remission and mapping out history-themed travel excursions—something he never thought he'd ever be able to do a few months ago.

<h2>How Does Belantamab Mafodotin Work?</h2>

Belantamab mafodotin is an antibody-drug conjugate (ADC), a new class of cancer drugs. The drug's antibody component targets a protein (BCMA) on the outside of myeloma cells. After binding to the cancer cell, the complex is taken into the cell where it drops off a potent chemotherapy drug, essentially killing it from within.

This internal targeting results in much less collateral damage to normal cells—a major problem with standard chemotherapy—and decreases the overall treatment burden.

Although thought to be less toxic than many standard therapies, belantamab mafodotin is not without adverse effects. Patients can have dry eyes, blurred vision, and occasionally more severe ocular toxicity due to the mechanism of action of the drug leaking into surrounding tissues after cell kill.

Clinical teams are trained to monitor and manage these effects, often adjusting dosage or incorporating supportive therapies to preserve patient safety.

Health Minister Karin Smyth emphasized the significance of this development: “This groundbreaking therapy puts the NHS at the forefront of cancer innovation. By harnessing cutting-edge ‘Trojan horse’ technology, we’re offering new hope to blood cancer patients across the country.”

In fact, the move by the NHS to be the first healthcare system in the world to introduce this treatment establishes a precedent for the incorporation of high-cost, high-impact biologic therapies into national care.

With its effective implementation in England, belantamab mafodotin could soon be used as a worldwide standard of care for relapsed or refractory multiple myeloma. As other nations observe outcomes and cost-effectiveness trends, it is possible that health systems globally will look into implementing this Trojan horse technique.

Researchers in oncology are also looking at similar antibody-drug conjugates for other types of cancer, including breast, lung, and ovarian cancers—implying that we are just beginning to see what this technology has to give.

blood cancer

trojan horse cancer drug

belantamab mafodotin

multiple myeloma treatment

nhs blood cancer therapy

blenrep approval uk

antibody drug for myeloma

blood cancer breakthrough

The England National Health Service (NHS) is the world's first healthcare system to offer a revolutionary blood cancer treatment called a "Trojan horse" drug. The trailblazing treatment, officially known as belantamab mafodotin, has the potential to add years to the lives of thousands of patients fighting multiple myeloma, a vicious and currently untreatable form of bone marrow cancer.This innovation, now being rolled out to eligible patients throughout England, highlights the revolutionary promise of precision medicine and targeted treatments to change cancer care.How Does This Therapy Work?At the center of this medical innovation is belantamab mafodotin, also known as Blenrep and produced by GlaxoSmithKline. In contrast to traditional chemotherapy that gets into both healthy and cancer cells, this new medication uses a targeted approach: it binds to myeloma cells, enters them quietly, and delivers a fatal dose of chemotherapy directly within, effectively killing the malignancy from the inside out.This "Trojan horse" metaphor comes from Greek mythology, as Greek warriors entered the city of Troy disguised within a wooden horse. In the same way, this drug corrupts cancer cells by smuggling a toxic payload into them disguised as an antibody—spared most healthy tissues in the process.NHS England National Clinical Director for Cancer Professor Peter Johnson called the treatment "life-changing" and said, "Myeloma is an aggressive blood cancer, but the advent of belantamab mafodotin brings with it a new hope of highly extended disease control.Multiple myeloma is a plasma cancer that arises in plasma cells present in the bone marrow. Although there are continued advances in medicine, the disease is still incurable and relapsing in nature. The majority of patients have a pattern of recurrence after remission, requiring multiple treatment lines.Trials of belantamab mafodotin, particularly in combination with other drugs such as bortezomib and dexamethasone, have shown that the treatment can stop disease from progressing for a period of three years—three years longer than the 13-month postponement achieved with the drug of choice at present, daratumumab.The National Institute for Health and Care Excellence (NICE), having checked the effectiveness and value for money, accelerated approval for the rollout of the treatment. NICE director Helen Knight stated, "This recommendation shows our determination to get patients the best treatment quickly while protecting value for the taxpayer." Who Will Benefit?The NHS rollout will first address about 1,500 patients per year in England that have relapsed or are resistant to their existing treatments. These are often those with advanced myeloma who have run out of other standard treatments.Significantly, this represents a move toward personalized, next-generation treatments being accessible through public healthcare facilities—an accomplishment welcomed by health activists and oncologists alike.Shelagh McKinlay, Myeloma UK's Director of Research and Advocacy, hailed the announcement: "We have campaigned aggressively for the last year to get this drug approved. It will change the lives of thousands of myeloma patients."Paul Silvester, who is 60 and from Sheffield, was diagnosed with multiple myeloma in 2023. When ordinary treatment and even a bone marrow transplant did not halt the disease, he was put on an early-access trial for belantamab mafodotin at the Royal Hallamshire Hospital.The change was almost instant," he explained. "In the first two or three weeks following the first dose, I was in remission. I like to think this treatment has brought the party balloons into the house."Paul is now in remission and mapping out history-themed travel excursions—something he never thought he'd ever be able to do a few months ago.How Does Belantamab Mafodotin Work?Belantamab mafodotin is an antibody-drug conjugate (ADC), a new class of cancer drugs. The drug's antibody component targets a protein (BCMA) on the outside of myeloma cells. After binding to the cancer cell, the complex is taken into the cell where it drops off a potent chemotherapy drug, essentially killing it from within.This internal targeting results in much less collateral damage to normal cells—a major problem with standard chemotherapy—and decreases the overall treatment burden.Side Effects and Safety IssuesAlthough thought to be less toxic than many standard therapies, belantamab mafodotin is not without adverse effects. Patients can have dry eyes, blurred vision, and occasionally more severe ocular toxicity due to the mechanism of action of the drug leaking into surrounding tissues after cell kill.Clinical teams are trained to monitor and manage these effects, often adjusting dosage or incorporating supportive therapies to preserve patient safety.Health Minister Karin Smyth emphasized the significance of this development: “This groundbreaking therapy puts the NHS at the forefront of cancer innovation. By harnessing cutting-edge ‘Trojan horse’ technology, we’re offering new hope to blood cancer patients across the country.”In fact, the move by the NHS to be the first healthcare system in the world to introduce this treatment establishes a precedent for the incorporation of high-cost, high-impact biologic therapies into national care.With its effective implementation in England, belantamab mafodotin could soon be used as a worldwide standard of care for relapsed or refractory multiple myeloma. As other nations observe outcomes and cost-effectiveness trends, it is possible that health systems globally will look into implementing this Trojan horse technique.Researchers in oncology are also looking at similar antibody-drug conjugates for other types of cancer, including breast, lung, and ovarian cancers—implying that we are just beginning to see what this technology has to give.

About Us

Contact Us

Terms & Conditions

Privacy Policy

Company

Health and Me is a premium website with content written and curated to function as a handbook for all Health concerns.